[Quality monitoring of cancer care pathways].
Monitoring of the cancer patient pathway in Denmark is characterized by fragmentation along the pathway as well as across the usual dimensions of quality assessment (i.e. clinical, organizational and patient-perceived quality). There are many sources of data but no single organisation has a comprehensive overview. Especially at the beginning (the GPs) and at the end (rehabilitation) of the pathways, there are severe monitoring gaps. In the field of cancer treatment, the best data is clinical, while organizational data is patchy and patient-perceived quality is just about to gain foothold. Addressing these monitoring challenges is necessary to provide an accurate picture of the overall quality of Danish cancer care.
Laursen
Søren Worsøe
SW
Kraeftens Bekaempelse, Kvalitetsenheden, DK-2100 København Ø. swl@cancer.dk
Knudsen
Janne Lehmann
JL
D019091:Critical Pathways / Q000592:standards*; D003718:Denmark / Q000453:epidemiology; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D017063:Outcome Assessment, Health Care; D011785:Quality Assurance, Health Care